Publications by authors named "Chao-Rong Xue"

Claim this Profile
S
SIK2 represses AKT/GSK3β/β-catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases.
Xiao-Man Dai, Yan-Hui Zhang, Xiao-Han Lin, Xiao-Xing Huang, Yi Zhang, Chao-Rong Xue

Mol Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K/AKT inhibitors aggravate death receptor-mediated hepatocyte apoptosis and liver injury.
Wei Liu, Zhen-Tang Jing, Chao-Rong Xue, Shu-Xiang Wu, Wan-Nan Chen

Toxicol Appl Pharmacol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer.
Xian-Qiang Chen, Chao-Rong Xue, Ping Hou, Bing-Qiang Lin, Jun-Rong Zhang

World J Gastroenterol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AKT activator SC79 protects hepatocytes from TNF-α-mediated apoptosis and alleviates d-Gal/LPS-induced liver injury.
Zhen-Tang Jing, Wei Liu, Chao-Rong Xue, Shu-Xiang Wu, Wan-Nan Chen

Am J Physiol Gastrointest Liver Physiol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis